UPDATE: Skyline Medical (SKLN) Closes Offering of Common Stock and Warrants for Proceeds of $1.98M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Skyline Medical (SKLN) Appoints New CEO, Board Member
December 2, 2016 8:31 AM ESTSkyline Medical Inc. (Nasdaq: SKLN) announced changes in executive management and the board of directors. Dr. Carl Schwartz, who currently serves as executive chairman, has been named the Companys chief executive officer and will continue to serve as a director. Richard Gabriel, co-founder and chief operating officer of GLG Pharma, has been appointed to the Companys board of directors, bringing the number of directors to six. Both appointments are effective immediately.
Dr. Schwartz became a director of the Company in March 2016 and was Skylines interim chief executive officer from... More
Skyline Medical (SKLN) Files to Offer Common Stock and Warrants
November 29, 2016 5:14 PM ESTSkyline Medical (NASDAQ: SKLN) disclosed in an SEC filing:
We are offering to three institutional investors up to 756,999 shares of our common stock, par value $0.01 per share, and Series C Warrants to purchase up to an aggregate of 756,999 shares of our common stock, par value $0.01 per share, pursuant to this prospectus supplement and the accompanying prospectus. The common stock and Series C Warrants will be sold in units (the Units), with each unit consisting of one share of common stock and a Series C Warrant to... More
